Ask about HGH (Somatropin)

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

HGH (Somatropin)

Also known as: Somatropin, Human Growth Hormone, GH

GH/GHRH FDA Approved

Recombinant human growth hormone

Mechanism of Action

Directly raises GH/IGF-1, driving growth, body-composition changes, and recovery. FDA-approved for growth hormone deficiency and specific conditions.

Note: Approved for GH deficiency and specific indications (prescription)

2,157
Community Posts
474
Users Discussing
37
Research Articles
13
Clinical Trials

Reported Outcomes

Clinical grade reflects published research; Community grade reflects user reports (n=2,157).

Growth Hormone

Effects on growth hormone levels

Clinical: A
Community: B
100% (2153)
Sleep Quality

Effects on sleep quality

Clinical: D
Community: B
30% (250)
Body Composition

Changes in muscle vs fat ratio

Clinical: B
Community: B
26% (279)
Energy Levels

Changes in energy and fatigue levels

Clinical: D
Community: A
9% (60)
Mental/Mood

Effects on mood and cognitive function

Clinical: D
Community: B
9% (62)
Muscle Repair

Muscle recovery and repair from exercise or injury

Clinical: D
Community: A
2% (7)

Who Discusses HGH (Somatropin)

From community reports with demographic data.

Gender (limited data)

Male 93%
Female 7%

n=60

Age Distribution (limited data)

48
median age
range: 33-59
30s
40s
50s

n=22

Side Effects

Limited data

Based on 7 user reports (n=7). Frequency indicates how often each was mentioned.

Uncommon (1-5%)

Injection Site Reaction (Isr)
Mild 1 reports 6.7%
Pain
Mild 1 reports 6.7%
High Estrogen
Mild 1 reports 6.7%
Injection Site Reaction
Mild 1 reports 6.7%
Fatigue
Mild 1 reports 6.7%
Sleepiness
Mild 1 reports 6.7%
Joint Pain
Mild 1 reports 6.7%

Risks & Warnings

Important safety considerations based on clinical data and community reports.

!

Carpal Tunnel

34 mentions

May occur with elevated GH levels. Usually resolves with dose adjustment.

!

Psychiatric Effects

4 mentions

Monitor for mood changes. Report any concerning psychiatric symptoms to healthcare provider.

i

Water Retention

57 mentions

Fluid retention can occur with GH-releasing peptides. Usually mild and temporary.

i

Injection Site Reactions

22 mentions

Local reactions are common and usually mild. Rotate injection sites.

Dosing

Standard Protocol

Starting Dose
1-2 IU/day (community); clinical dosing is indication-based
Titration
Indication-based (clinical) / cycled (community)
Half-life
~3-5 hours
Administration
Subcutaneous injection, daily
FDA-Approved Doses
Indication-based (e.g., 0.2-0.4mg/day)

Community Dosing Patterns

Based on 86 mentions

Community-reported patterns, not medical advice.

2iu daily
10
1iu daily
6
4iu daily
6
daily
4
3iu daily
3

Research

37
Total Articles
13
Clinical Trials
6
Reviews

Key Studies

Commonly Stacked With

From community members' documented stacks involving HGH (Somatropin).

Retatrutide 78 stacks (63.9%)
Tesamorelin 15 stacks (12.3%)
Tirzepatide 15 stacks (12.3%)
BPC-157 14 stacks (11.5%)
TB-500 11 stacks (9%)

Switching Patterns

Based on 131 discussions about switching to or from HGH (Somatropin).

Switching FROM

Retatrutide 28 mentions
Tesamorelin 10 mentions
MOTS-c 6 mentions
Tirzepatide 5 mentions

Users who switched to HGH (Somatropin)

Switching TO

Retatrutide 18 mentions
Tirzepatide 4 mentions
Tesamorelin 3 mentions
CJC-1295 3 mentions

Users who switched from HGH (Somatropin)